Glenn Baity, EVP AND GC at ACADIA PHARMACEUTICALS INC (ACAD), sold 16,000 shares at $35.00 ($560K) on 2016-07-11, disclosed to the SEC on 2016-07-13.
Scheduled sale ($560k) by EVP AND GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.00 | 4,057 | $142K | 25.4% |
| 2 | $35.00 | 11,943 | $418K | 74.6% |
| Total | $35.00 avg | 16,000 | $560K | 100% |
| Filing → |
| ACAD | SELL | 2017-10-06 | $3.1M | — | Filing → |
| ACAD | SELL | 2017-09-01 | $924K | — | Filing → |
| ACAD | SELL | 2017-08-11 | $500K | — | Filing → |